The First Genital Ulcer PCR Kit with MPXV Detection
We’re pleased to introduce Vircell’s Genital Ulcer Real‑Time PCR kit, a comprehensive multiplex assay designed to support fast, accurate diagnosis of genital ulcer disease (GUD). With overlapping clinical presentations across HSV, syphilis, LGV, chancroid, VZV and MPXV, this assay provides the clarity clinicians need to guide appropriate management. ¹
Key features:
- Detects 7 key pathogens from genital skin lesions or perianal/rectal exudates:
- Chlamydia trachomatis serovar L (LGV)
- Herpes simplex virus type 1 (HSV‑1)
- Herpes simplex virus type 2 (HSV‑2)
- Treponema pallidum (syphilis)
- Haemophilus ducreyi (chancroid)
- Varicella‑zoster virus (VZV)
- Monkeypox virus (MPXV) – first genital ulcer kit on the market to include MPXV
- Two‑tube multiplex PCR per sample (Mix A + Mix B)
- Internal control in both mixes to monitor inhibition and amplification setup
- Lyophilised master mix and positive control for stability and reduced transport costs
- Fast and reliable results in < 2 hours
- Pre‑dispensed 96 × 0.1 mL tear‑off strip format for flexible batch size
- Compatible with major 5‑channel qPCR cyclers (FAM, HEX/VIC, Texas Red/ROX, Cy5, Q705)
- High analytical sensitivity and specificity across all targets
Learn more about Vricell Genital Ulcer Real-Time PCR
Molecular Biology 2026 Catalogue
Infectious Immunology 2026 Catalogue
*Not all Vircell IVD products are included on the Australian Register of Therapeutic Goods (ARTG). Please contact Abacus dx to check on their regulatory status.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
References:
- Centers for Disease Control and Prevention (CDC) (n.d.) Genital ulcers – STI treatment guidelines. Available at: https://www.cdc.gov/std/treatment-guidelines/genital-ulcers.htm (Accessed: 7 April 2026).